Paul J. Sekhri

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Pleasanton, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/Kevin R. Lind, Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Paul J. Sekhri

Form 4 holding Pres, CEO and Exec Chairperson, Director

vTv Therapeutics Inc.

Security class
Employee stock option (right to buy)
Shares / value
252,212
Estimated value
$4,958,488
Report date
01 Mar 2025
Price
$19.66
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
Form 4 holding Director

BiomX Inc.

Security class
Common Stock
Shares / value
12,500
Estimated value
$4,250
Report date
28 Jul 2021
Price
$0.3400
Ownership
Direct
Form 4 holding Director

Axcella Health Inc.

Security class
Stock Option (Right to Buy)
Shares / value
40,000
Estimated value
Report date
19 May 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Longboard Pharmaceuticals, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
22,500
Estimated value
Report date
23 May 2024
Price
Ownership
Direct
Underlying class
Voting common stock
Underlying amount
Form 4 holding Director

Apnimed, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
22,238
Estimated value
Report date
03 Aug 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Apnimed, Inc.

Security class
Common Stock
Shares / value
12,500
Estimated value
Report date
03 Aug 2026
Price
Ownership
Direct
Form 4 holding Director

BiomX Inc.

Security class
Common Stock Warrant
Shares / value
9,375
Estimated value
Report date
28 Jul 2021
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Longboard Pharmaceuticals, Inc.

Security class
Employee Stock Option (right to buy)
Shares / value
0
Estimated value
Report date
02 Dec 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Paul J. Sekhri

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .